Kim S, Ghiringhelli F, de la Fouchardiere C, Evesque L, et al. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study. Lancet Oncol 2024;25:518-528.
PMID: 38547895